Ross, D. M., Babon, J. J., Tvorogov, D. and Thomas, D. (2021) ‚ÄúPersistence of myelofibrosis treated with ruxolitinib: biology and clinical implications‚ÄĚ, Haematologica. Pavia, Italy, 106(5), pp. 1244-1253. doi: 10.3324/haematol.2020.262691.